Citalopram to treat depression in pediatric oncology

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 3, 2007, Pages 371-377

  DeJong, Margaret ^a   Fombonne, Eric ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; CANCER PATIENT; CASE REPORT; CHILD PSYCHIATRY; CHILDHOOD CANCER; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; ONCOLOGY; OPEN STUDY; SCHOOL CHILD; TREATMENT DURATION; UNITED KINGDOM;

ADOLESCENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CITALOPRAM; CRANIOPHARYNGIOMA; DEPRESSIVE DISORDER; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; SEROTONIN UPTAKE INHIBITORS;

EID: 34447506372     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.0076     Document Type: Article

References (27)

1. Ambrosini PJ: Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J Am Acad Child Adolesc Psychiatry 39:49-58, 2000.
2. American Psychiatric Association (APA): Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). Washington, DC, American Psychiatric Association, 1994.
3. Angold A, Costello EJ, Messer SC: Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. J Methods Psychiatr Res 5:237-249, 1995.
4. Bezchlibnyk-Butler K, Aleksic I, Kennedy SH: Citalopram - a review of pharmacological and clinical effects. J Psychiatry Neurosci 25:241-254, 2000.
5. Brosen K, Naranjo CA: Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol 11:275-283, 2001.
6. Cadman D, Boyle M, Szatmari P, Offord D: Chronic illness, disability, and mental and social well-being: Findings of the Ontario Child Health Study. Pediatrics 79:805-812, 1987.
7. Campo JV, Perel J, Lucas A, Bridge J, Ehmann M, Kalas C, Monk K, Axelson D, Birmaher B, Ryan N, Di Lorenzo C, Brent DA: Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: An exploratory study. J Am Acad Child Adolesc Psychiatry 43:1234-1242, 2004.
8. Carlsson B, Olsson G, Reis M, Walinder J, Nordin C, Lundmark J, Scordo MG, Dahl M-J, Bengtsson F, Ahlner J: Enantioselective analysis of Citalopram and metabolites in adolescents. Ther Drug Monit 23:658-664, 2001.
9. Committee of Safety of Medicines (CSM): Selective Serotonin Reuptake Inhibitors (SSRI's): overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data. Accessed at http://medicines.nhra.gov.uk/ ourwork/monitorsafequalmed/safety messages/ssrioverview_101203.htm, 2003.
10. DeJong M and Fombonne E: Depression in paediatric cancer: An overview. Psycho-oncology 15:553-566, 2006.
11. Drotar D: Relating parent and family functioning to the psychological adjustment of children with chronic health conditions: What have we learned? What do we need to know? J Pediatr Psychol 2:149-165, 1997.
12. Food and Drug Administration (FDA) Public Health Advisory: Suicidality in children and adolescents being treated with antidepressant medications. Accessed at http://www.fda.gov/cder/drug/antidepressants/SSRIPHA200410.htm, 7 July, 2006.
13. Gothelf D, Rubinstein M, Shemesh E, Miller O, Farbstein I, Klein A, Weizman A, Apter A & Yaniv I: Pilot Study: Fluvoxamine Treatment for Depression and Anxiety Disorders in Children and Adolescents with Cancer. J Am Acad Child Adolesc Psychiatry 44:1258-1262, 2005.
14. Harris JC, Carel CA, Rosenberg LA, Joshi P, Levanthal BG: Intermittent high dose corticosteroid treatment in childhood cancer: Behavioural and emotional consequences. J Am Acad Child Adolesc Psychiatry, 25:120-124, 1986.
15. Kutcher S: Child & Adolescent Psychopharmacology. Philadelphia, WB Saunders Company, 1997.
16. Messer SC, Angold A, Costello EJ, Loeber R, Van Kammen W, Stouthamer-Loeber M: Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents: Factor composition and structure across development. Int J Methods Psychiatric Res 5:251-262, 1995.
17. Mitchell AJ: Two-week delay in onset of action of antidepressants: New evidence. Br J Psychiatry 188:105-106, 2006.
18. National Institute for Health and Clinical Excellence. Depression in children and young people: Identification and management in primary, community and secondary care. National Clinical Practice Guideline 28. The British Psychological Society and The Royal College of Psychiatrists (UK), 2005.
19. Pao M, Ballard ED, Rosenstein DL, Wiener L, Wayne AS: Psychotropic medication use in pediatric patients with cancer. Arch Pediatr Adolesc Med 160:818-822, 2006.
20. Popkin MK, Tucker GJ: Mental Disorders due to a mental condition and substance-induced disorders: Mood, anxiety, psychotic, catatonic and personality disorders. In: DSM-IV Sourcebook. Washington DC, APA Office of Research, 1994, pp 243-276.
21. Rasmussen SL, Overo KF, Tanghoj P: Cardiac safety of citalopram: Prospective trials and retrospective analyses. J Clin Psychopharm 19:407-415, 1999.
22. Rutter M: Education, Health and Behaviour. London, Longman, 1970.
23. Thomsen PH, Ebbesen C, Persson C: Long-term experience with citalopram in the treatment of adolescent OCD. J Am Acad Child Adolesc Psychiatry 40:895-902, 2001.
24. Wagner KD: Pharmacotherapy for major depression in children and adolescents. Progr Neuro-Psychopharm Biol Psychiatry 29:819-826, 2005.
25. Wagner KD, Robb AS, Findling RL, Jin J, Gutierrez MM, Heydorn WE: A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents 161:1079-1083, 2004.
26. Whittington CJ, Kendall T, Fonagy, P, Cottrell D, Cotgrove A, Boddington E: Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. The Lancet 363:1341-1345, 2004.
27. Wood A, Kroll L, Moore A, Harrington R: Properties of the Mood and Feelings Questionnaire in adolescent psychiatric outpatients: A research note. J Child Psychol Psychiatr 36:327-334, 1995.